|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 275, Issue 49, 38355-38362, December 8, 2000
From the
Received for publication, August 18, 2000
A large variety of proenkephalin-A-derived
peptides (PEAPs) are present in bovine adrenal medulla secretory
granules that are cosecreted with catecholamines upon stimulation of
chromaffin cells. In the present paper, after reverse phase high
performance liquid chromatography of intragranular soluble material,
PEAPs were immunodetected with antisera raised against specific
proenkephalin-A (PEA) sequences (PEA63-70 and PEA224-237) and
analyzed by matrix-assisted laser desorption ionization-time of flight
(MALDI-TOF) mass spectrometry. Thirty PEAPs were characterized in
addition to enkephalins and whole PEA, indicating that preferential
proteolytic attacks occurred at both N- and C-terminal regions. A
similar approach was used to characterize PEA-derived fragments
exocytotically released into the extracellular space that showed five
additional minor PEAPs. Among all these naturally generated peptides,
enkelytin, the antibacterial bisphos- phorylated C-terminal peptide
(PEA209-237), was predominantly generated, as shown by MALDI-TOF mass
spectrometry analysis, which constituted an efficient method for its
identification. Finally, the data on PEA intragranular and
extracellular processing in adrenal medulla are discussed in regard to
the known enzymatic processing mechanisms. We note the high
conservation of the cleavage points in evolutionarily diverse
organisms, highlighting an important biological function for the
released PEAPs.
Secretory granules in the bovine adrenal medullary chromaffin
cells contain a complex mixture of secretory products that are co-released with catecholamines into the circulation in response to
splanchnic nerve stimulation (1, 2). Among the high
molecular mass water-soluble proteins, proenkephalin-A
(PEA)1 and a family of
acidic proteins, named chromogranins, constitute the major constituents
of the chromaffin granules. These proteins are considered as protein
precursors and are actively processed to low molecular weight peptides.
Previously, we have characterized the intragranular and extracellular
processing of chromogranin A and B (3, 4) in chromaffin granules from
bovine adrenal medulla. PEA generates enkephalins, other opioid
peptides, and other derived peptides (PEAPs), which display various
biological effects, including antinociception and immunomodulation (5). Because large amounts of enkephalins and enkephalin-containing peptides
are found in adrenal medullary chromaffin granules, these organelles
represent an excellent model to study the intragranular processing of
PEA (6-8). Several opioid peptides, including Met-enkephalin and
Leu-enkephalin in the ratio 4:1, the opioid heptapeptide
(Met-enkephalin-Arg-Phe), the opioid octapeptide
(Met-enkephalin-Arg-Gly-Leu) and C- or N-terminally extended variants
of these peptides are liberated by cleavage of the PEA at pairs of
basic residues (6, 9). In addition, processing of PEA has been analyzed
in stably transfected mouse anterior pituitary tumor (AtT-20) cells
(10), showing that PEA processing proceeds through an orderly series of
steps. Similarly to other precursors, PEA processing appears to start with the removal of the bovine C-terminal peptide B (PEA209-239) (10,
11).
Since 1995, we have shown that antibacterial activities are present
within the intragranular chromaffin granule matrix and are recovered in
the extracellular medium following secretion. This activity has been
assigned to chromogranin A and B fragments and PEAPs (4, 12-17). Among
the intragranular matrix components, enkelytin, an antibacterial
peptide corresponding to the bisphosphorylated fragment PEAP209-237,
was identified (14). The antibacterial spectrum of enkelytin shows that
this peptide is active in the micromolar range against several
Gram-positive bacteria including Staphylococcus aureus, but
it is not able to inhibit Gram-negative bacterial growth nor to lyse
erythrocytes (15). In addition, the two antibacterial C-terminal PEAPs,
enkelytin (PEAP209-237) and the bisphosphorylated peptide B
(PEAP209-239) are secreted from stimulated cultured chromaffin cells
and are immunodetectable in wound fluids and polymorphonuclear
neutrophil secretions (15). The co-release of enkelytin and
PEAP209-239 with catecholamines suggests that in stressful situations,
these peptides may play an important role in defense mechanisms.
Recently, we have described the release of the antibacterial form of
the peptide B in the hemolymph of leech (Theromyzon
tessulatum) and mussel (Mytilus edulis) following
lipopolysaccaride stimulation, surgical trauma, and electrical
stimulation of the neural tissues (18). Thus, the antibacterial
C-terminal fragments PEA209-237/239 that are expressed in the nervous
and immune systems appear to be highly conserved during evolution and
may provide a basis for neuroimmune interactions (5, 15).
In the present work, we used reverse phase HPLC, peptide sequencing and
matrix-assisted laser desorption ionization-time of flight (MALDI-TOF)
mass spectrometry to identify all the PEAPs (in addition to Leu- and
Met-enkephalins and whole PEA) present in chromaffin granules and
chromaffin cell secretions. Thirty PEAPs have been characterized,
indicating that preferential proteolytic attacks are located at the N-
and C-terminal regions (PEA1-116 and PEA209-239, respectively), as
well as 16 new proteolytic cleavage sites. Among all the naturally
released PEAPs, enkelytin, the antibacterial C-terminal fragment
corresponding to the bisphosphorylated form (Ser221 and
Ser223) of PEA209-237 was a predominant component.
In addition, MALDI-TOF mass spectrometry is a very efficient tool for
the identification of peptides in biological materials.
Preparation of Soluble Material Present in Chromaffin
Granules--
Secretory granules were isolated from bovine adrenal
medulla according to Smith and Winkler (19), except that sucrose
solutions were buffered with 10 mM Hepes (pH 7). Granules
were lysed by successive freezing and thawing in 10 mM
Hepes (pH 7). Granule membranes were sedimented by centrifugation at
100,000 × g for 30 min (20). The supernatant was
collected, and aliquots were stored at Isolation of Proteins Released from Stimulated Cultured
Chromaffin Cells--
Chromaffin cells were isolated from fresh bovine
adrenal glands and cultured as described previously (3). Cells were
plated at a density of 107 cells/50 mm in plastic Petri
dishes. After 3 days in culture, the medium was removed, and cells were
washed four times with Locke's solution (140 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO4, 2.5 mM CaCl2, 11 mM glucose, 0.5 mM ascorbic acid, 15 mM Hepes, pH 7.5) and
subsequently stimulated for 10 min with Locke's solution containing 10 µM nicotine. External medium was carefully collected,
completed with trifluoroacetic acid up to 0.1%, lyophilized, and
stored at Purification of PEAPs by Reverse Phase HPLC--
PEAPs were
isolated using the Applied Biosystems HPLC system 140 B. Chromatography
was performed on a Macherey Nagel Nucleosil 300-5C18 column (4 × 250 mm; particle size, 5 mm). Absorbance was monitored at 214 nm, and
the solvent system consisted of 0.05% (v/v) trifluoroacetic acid in
water (solvent A) and 0.05% (v/v) trifluoroacetic acid in acetonitrile
(solvent B). Elution was performed at a flow rate of 700 µl/min using
gradient as shown on chromatogram.
Sequence Analysis of PEAPs--
The sequence of purified
peptides was determined in our laboratory by automatic Edman
degradation on an Applied Biosystems 473A microsequencer. Samples
purified by HPLC were loaded on polybrene-treated and precycled glass
fiber filters (3). PTH-derivatives (Pth-Xaa) were identified by
chromatography on a C-18 column (PTH C-18, 2.1 × 200 mm).
Mass Spectra Analysis--
Mass determination was carried out in
our laboratory on a Brucker BIFLEXTM MALDI-TOF equipped
with the SCOUTTM system, High Resolution Optics with X-Y
multisample probe, a gridless reflector, and the HIMASTM
linear detector. This instrument has a maximum accelerating potential of 30 kV and may be operated either in the linear or reflector mode.
Ionization was accomplished with a 337-nm beam from a nitrogen laser
with a repetition rate of 3 Hz. The output signal from the detector was
digitized at a sampling rate of 250 MHz in linear mode and 500 MHz in
reflector mode using a 1 GHz digital oscilloscope (Lecroy model). The
instrument control and data processing were accomplished with software
supplied by Bruker using a Sun Sparc workstation. These studies were
realized using as the matrix Western Blot Analysis--
Soluble intragranular proteins were
separated on a SDS-polyacrylamide gel containing 17% acrylamide (22).
To detect immunologically reactive fragments, proteins were
electrotransferred to nitrocellulose sheets (23), and immunodetection
was performed as previously reported (3).
Processing of PEA in bovine chromaffin granules
Direct MALDI-TOF Analysis of HPLC Fractions from Soluble
Intragranular Material--
Immediately after the preparation of
soluble material from bovine chromaffin granules, a separation by
chromatography on a reverse phase C-18 column was performed (Fig.
1A). PEAPs were recovered in
fractions labeled 1-3, according to the immunoreactivity with antisera
raised against NH2- and COOH-specific peptides (PEAP63-70 and PEAP224-237, respectively; Fig. 1B). By comparison with
the theoretical molecular mass deduced from the PEA amino acid sequence (24), we have attributed several experimental values obtained after
MALDI-TOF mass spectrometry of HPLC fractions 1-3 (Fig. 1C). In fraction 1, we have identified the N-terminal
fragment PEA1-70 (7731.9 Da) and different forms of the C-terminal
peptide 209-237, corresponding to non-phosphorylated PEAP209-237
(3355.7 Da) and the mono-, bis-, and tri-phosphorylated forms (3434.3, 3513.6, and 3594.0 Da), as shown in the spectrum window 3200-3900 (Fig. 2). Interestingly, by direct
MALDI-TOF analysis, enkelytin, the antibacterial peptide corresponding
to the major and bisphosphorylated form (Ser221,
Ser223) of PEA209-237 (14), was easily identified by its
specific molecular mass (3513.6 Da). Direct MALDI-TOF analysis of
fraction 2 indicated three peptides located in the core of PEA and
corresponding to PEA80-106 (3007.1 Da), PEA80-115 (4098.8 Da), and
PEA116-162 (4998.8 Da). Fraction 3 corresponds to large fragments
located in the PEA1-223 (Fig. 1B) and characterized after
additional purifications (see below).
To characterize all the PEAPs present in the other fractions (Fig.
1A), sequencing and mass spectrometry analysis were
performed on the fractions eluted before and after peaks a and c,
respectively. Only, Met- and Leu-enkephalins were found in the peaks
preceding the fraction 1, whereas entire PEA was found in the peak
eluted at 40% acetonitrile (data not shown).
Repurification and Analysis by Sequencing and MALDI-TOF Mass
Spectrometry of Intragranular PEAPs--
To complete this study,
additional purifications by reverse phase HPLC were performed to (i)
further identify the complex peptide mixture present in fraction 1, (ii) characterize the immunodetected N-terminal fragments (antisera
63-70) present in fractions 2 and 3 (Fig. 1B), and (iii)
elucidate the structure of median PEAPs located within the PEA core
(). Thus, one of the repurification steps of fraction 2 is shown
in Fig. 3A. Five fractions
(a-e) were recovered and analyzed by the combination of sequencing and MALDI-TOF analysis (Fig. 3B). Five different PEAPs were
identified, corresponding to sequences located in the core of the
protein (, , ); two peptides are located in the
N-terminal moiety (1-68 and 1-74). These data are in accordance with
the Western blot results (Fig. 1B). Two distinct fractions
(d and e) contain an unique sequence corresponding to PEAP1-74, which
suggests the presence of a thin difference in the spatial conformation
of the peptides that may induce a difference in the elution of the
peptide. For instance, this fragment includes three glutamine and one
asparagine residues that may be partially deamidated during
preparation, introducing additional negative charges to the molecule.
The analysis of peak a (Fig. 1A) shows the presence of
PEAP80-105 and 80-106, which corresponds, respectively, to the
amidorphin and its extended form. Finally, analysis of PEAPs included
in fraction 1 allowed us to identify three N-terminal fragments
(PEA1-68, PEA1-74, and PEA1-77), a median peptide (PEA116-155), and
five C-terminal fragments corresponding to PEA209-232 (non-, mono-,
and bis-phosphorylated), PEA209-235, and the phosphorylated form of
PEA211-237, whereas the study of fraction 3 led to the
characterization of PEA1-165 and PEA116-196. Thus, this complete
analysis of the soluble intragranular material shows the presence of 25 different PEAPs (Table I) as the result
of a complex proteolytic mechanism occurring along the polypeptide
chain of PEA. These data are summarized in Fig. 4.
Processing of PEA in Material Released from Nicotine-stimulated
Cultured Chromaffin Cells
After stimulation of cultured chromaffin cells with 10 µM nicotine, PEAPs present in the extracellular medium
were separated by HPLC on a reverse phase C-18 column (Fig.
5A). Analysis of peaks 1-3 by
sequencing and MALDI-TOF mass spectrometry (Fig. 5B)
revealed that peaks 1 and 2 contain C-terminal fragments
PEA209-237/239 with one, two, and three phosphate groups, whereas peak
3 contains a mixture of N- and C-terminal fragments PEA1-69/70/72 and
PEA230-237. It is important to note that the predominant fragments
exocytotically released from nicotine-stimulated cultured chromaffin
cells were located in the N-terminal domain (PEA1-72, synenkephalin)
and also in the C-terminal domain (PEA209-239) of the precursor (Fig. 4). Furthermore, the three cleavage sites Leu-Ala (69-70), Ala-Lys (70-71), and Met-Glu (229) correspond to new proteolytic
attacks that have not yet been identified. Interestingly, the mono- and bis-phosphorylated forms of PEA209-239 are concomitantly recovered in
fractions 1 and 2. Because three phosphorylation sites
(Ser215, Ser221, and Ser223; Fig.
4) are present in PEA, the fragments recovered in fractions 1 and 2 are
not phosphorylated at identical positions, leading to different elution
times. Taking together, the analysis of the PEAPs released in the
extracellular space upon nicotine cell stimulation led to the
identification of five new fragments, resulting from extracellular
processing.
It is well documented that pro-hormones and pro-neuropeptides are
synthesized as inactive large precursors that are processed during
their intracellular transport and their storage to generate active
peptides (25, 26). Conversion of these precursors to smaller
biologically active peptides requires specific proteolytic cleavages.
Thus, several endopeptidases (cleaving inside the protein sequence) and
exopeptidases (removing amino acids from the NH2- and
COOH-ends) are involved in PEA maturation (6). The knowledge of
pro-hormone and pro-neuropeptide processing and of its relationship to
the secretory pathway has significantly progressed during the last 5 years. In the trans-Golgi network, pro-hormones are thought to be sorted with processing enzymes into regulated secretory vesicles
(27). Within these organelles, pro-hormone processing is dependent on
condensation-induced protein organization, on calcium concentration
that may reach several mM (i.e. 20 mM in chromaffin granules), and on pH that is below 6.0 in
most endocrine and neuroendocrine secretory granules (27, 28).
Pro-hormone cleavage, occurring mainly at specific paired basic sites,
takes place in a strict temporal order and is likely to involve a
variety of endoproteases. This processing is completed in some cases by the combined action of amino- and carboxy-peptidases.
In the present study we have identified 30 PEAPs generated during the
intragranular and extracellular processing of PEA. Some of these
peptides have never been described up to now. These data were made
possible by the combination of sensitive methods, in particularly
MALDI-TOF mass spectrometry, which allows for low level peptide analysis.
An initial screening, based on the expected molecular mass of three
immunoreactive fractions, resulting from the first HPLC purification of
the soluble intragranular material led to the characterization of eight
peptides. Analysis of fractions eluted before and after the peaks of
interest indicated the presence of enkephalins and whole PEA. Then
several additional purifications were crucial for the structural
characterization of minor but numerous PEAPs present in immunoreactive
fractions (Figs. 1 and 2). Further analyses identified 25 intragranular
PEAPs in fractions 1-3 (Table I). Six major cleavage sites are located
at positions 68-69 (Leu-Leu), 74-75 (Gly-Gly), 79-80 (Arg-Tyr),
115-116 (Lys-Asp), 208-209 (Arg-Phe), and 237-238 (Met-Arg),
according to the bovine PEA sequence (24) (Fig. 4). Proteolytic sites
located at positions 79-80, 115-116, 208-209, and 237-238 have been
previously described (6), whereas broken linkages 68-69 and 74-75
were identified in this study as new and major cleavage sites. In
addition, 12 minor cleavage sites were characterized along the PEA
polypeptide chain (Fig. 4), localized before dibasic sites such as
70-71 (Ala-Lys/Lys), 77-78 (Met-Lys/Arg), 106-107 (Gly-Lys/Arg),
113-114 (Met-Lys/Lys), 155-156 (Ser-Lys/Arg), and 165-166
(Leu-Lys/Arg) or after the dibasic sites 72-73 (Lys/Lys-Tyr) and
232-233 (Lsy/Arg-Tyr). Furthermore, cleavage points were identified at
positions 162-163 (Met-Arg) and 163-164 (Arg-Gly) on both sides of
Arg163 residue. Natural processing of Met-enkephalin was
also observed at positions 74-75 (Tyr/Gly-Gly/Phe/Met) and 235-236
(Tyr/Gly/Gly-Phe/Met). Additional endogenous splitting points were
characterized along the polypeptide chain in position outside the basic
residues such as 138-139 (Asp-Gln/Arg) and 196-197
(Met-Asp/Tyr/Gln/Lys), involving carboxypeptidases in combination with
different enzymes specific to basic residues and present in chromaffin
granules. Processing of the C-terminal moiety of PEA in positions
208-209, 210-211, 229-230, 232-233, 235-236, and 237-238
generated a complex mixture of peptides including non-, mono-, bis-,
and triphosphorylated forms.
Synenkephalin (PEAP1-72) was hardly detectable in the soluble
intragranular material, whereas it was described previously as a major
component (6). This was not due to further degradation occurring during
purification or due to storage conditions, because the addition of
protease inhibitors did not modify peptide patterns. However, we have
detected synenkephalin in the extracellular medium after stimulation of
cultured cells, indicating that this peptide is generated by
proteolysis of PEAP1-74 and actively processed to PEAP1-68.
The present experimental data also demonstrate that in chromaffin
granules two predominant C-terminal fragments are generated, the
bisphosphorylated forms of PEA209-237 (enkelytin) and of PEA209-239 (peptide B), which were described both to display antibacterial activity (14, 15). As described previously (11), the processing of PEA
may start at the C-terminal end in chromaffin granules. Interestingly,
during the processing of PEA, enkelytin is one of the major peptides
generated and complements the results obtained on invertebrates,
demonstrating the occurrence of a similar mechanism in animals 500 million years divergent from man in evolution (18). The direct
detection of enkelytin by MALDI-TOF analysis further demonstrates that
this new tool is useful and efficient for peptide detection and
analysis in biological fluids.
Since the first study of Udenfriend and Kilpatrick in 1984 (29) on PEA
processing, numerous groups looked for the presence of proteolytic
enzymes in the intragranular matrix and in the membranes of chromaffin
granules. The prohormones convertases 1/3 and 2 have been identified in
chromaffin cells and shown to be involved in PEA maturation (30). These
endopeptidases are members of the subtilisin-like enzyme family and
were identified because of their sequence homology with the yeast
endopeptidase Kex2 gene (31-35). These enzymes cleave the polypeptidic
chains at the C-terminal side of dibasic amino acids and at the
N-terminal side of a single arginine residue. In this regard, Lys-Arg
sites were mainly cleaved, whereas Lys-Lys or Arg-Lys sites were weakly cleaved (30, 35, 36). In chromaffin granules, 7B2, a protein related to
the chromogranin/secretogranin family, inhibits prohormone convertase 2 and plays a role in its chaperoning (33, 37, 38).
The prohormone thiol-protease is a multicatalytic cysteine protease
complex detected in chromaffin granules as a major PEA processing
enzyme (35, 39-42). Prohormone thiol-protease cleaves the polypeptidic
chain at the N-terminal side of dibasic residues or between the
Arg-Arg, Lys-Lys, and Lys-Arg sites or at the N-terminal side of a
single arginine residue (Gly-Arg) (41, 43, 44). Adrenorphin-Gly-generating enzyme was characterized to be present in
the adrenal medulla as an endopeptidase cleaving at the N-terminal side
of single arginine residues and at dibasic sites (45). The
proopiomelanocortin-converting enzyme, also named 70-kDa Asp-protease, is present in chromaffin cells and is mainly involved in the maturation of propiomelanocortin and PEA (35, 46). This enzyme cleaves between two
basic residues and at C-terminal side of the dibasic residue Lys-Arg
and Arg-Lys sites (pH optimum of 5.5). Furthermore, several serine
proteases (trypsin-like activity) have been described in chromaffin
cells of adrenal medulla and proposed to be involved in PEA maturation
(47); this group comprises an enzyme that cleaves mainly the Lys-Arg
bond (48), a serine protease of 30 kDa (47, 49, 50), as well as two
different enzymes with respective molecular masses of 76 and 30 kDa
(51). In addition, an endooligopeptidase A-like protein activity has
been identified in secretory granules of PC-12 cells (52). This enzyme
of 71 kDa is implicated in the conversion of enkephalin-containing
peptides into enkephalins. In addition, the presence of
peptidylglycine- As shown in Table II, the cleavage at 24 sites can be explained through
the activity of the different enzymes previously described to be
involved in PEA maturation (Table II). Among these 24 cleavage sites,
17 are located close to dibasic sites, five are located at the
proximity of arginine residue, and two result from the splitting of
weak peptidic bonds (Gly-Xaa or Xaa-Gly). Because acidic residues,
proline, and phosphorylated serine alter the proteolytic activities,
five dibasic sites (Lys85-Lys86,
Lys180-Arg181,
Arg187-Arg188, and
Lys200-Lys201) and six basic residues
(Lys49, Lys131, Arg140,
Lys176, Arg191, and Lys224) were
not the targets to these enzymes. Furthermore, the putative cleavage
sites close to the five basic residues included in the three-disulfide
bridge arrangement (Arg12, Arg15,
Lys31, Lys36, and Lys42) were not
used as such. In addition, prohormone convertases 1/3 and 2, prohormone thiol-protease, proopiomelanocortin-converting enzyme, the
serine proteases, and the carboxypeptidases are predominantly involved.
The peptidylglycine- Several publications described a different processing in other tissues such as brain (59), breast tumor cell lines (60), adenomas (61), bone marrow, and immune cells (62-64). PEA processing was described to be dependent on the age of the patients (65) or to stress (18, 66) and to be directly related to the proteolytic enzyme expressions that may depend on various environmental conditions (60). The complete analysis of the processing of PEA in bovine adrenal medulla chromaffin granules will assist in revealing the regulation and activation of proteolytic enzymes that are critical to signal molecule expression. Thus far, only few biological effects have been attributed to PEAPs. Enkephalins are known to exhibit analgesia (67), organ development (68), positive ionotropic effects in isolated heart muscle cells (69), as well as immunomodulatory activity (5, 70). Furthermore, among other PEAPs, the opioid heptapeptide (YGGFMRF) (71), BAM-12 and -22, as well as peptides E and F display analgesic effects (72). Synenkephalin-derived peptides were also recently described to be involved in human lymphocyte proliferation (64). As shown in Fig. 6, the major identified
cleavage sites exhibit a high phylogenetic conservation (73),
suggesting that these new peptides described here should be able to
share important biological activities among species. As an example,
enkelytin and its extended form PEA209-239, because of their relative
abundance, their conservation, and their antimicrobial activity, appear
to display an important role in neuroimmunity (74, 75).
We express our sincere gratitude to Geraldine Chartron for excellent assistance in the purification of proenkephalin-derived peptides. We are indebted to Dr. A. Van Dorsselaer for mass spectrometry determination (CNRS URA 31, Strasbourg).
* This work was supported by funds from the INSERM U.338, the Université Louis-Pasteur de Strasbourg (Pôle Neurosciences; Contrat pluriformation 97-00), the Ligue Départementale contre le Cancer (to M.-H. M.-B.), the Association Recherche et Partage (Ph.D. fellowship to K. L.), and Direction des Recherches, Etudes et Techniques Contract 96-099 (to D. A.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Published, JBC Papers in Press, September 14, 2000, DOI 10.1074/jbc.M007557200
The abbreviations used are: PEA, proenkephalin-A; HPLC, high performance liquid chromatography; MALDI-TOF, matrix-assisted laser desorption ionization-time of flight; PEAP, proenkephalin-A-derived peptide.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc. This article has been cited by other articles:
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||